A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma
Clinical trial NCT00272415 · TERMINATED
Trial details
- NCT number
- NCT00272415
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.